Free Trial

FibroGen (FGEN) SEC Filings & 10K Form

FibroGen logo
$0.41 0.00 (0.00%)
(As of 12/4/2024 ET)

Recent FibroGen SEC Filings

DateFilerForm TypeView
11/14/2024
3:52 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SC 13G/A
11/12/2024
1:33 PM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
11:11 AM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/03/2024
3:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:10 PM
FibroGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/10/2024
11:15 PM
FibroGen (Filer)
Form EFFECT
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
FibroGen (Subject)
Form SC 13G/A
06/28/2024
4:08 PM
FibroGen (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/26/2024
7:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:30 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
Adib Deyaa (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:37 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:12 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
7:00 PM
Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:46 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
8:55 PM
FibroGen (Filer)
Form ARS
04/24/2024
4:01 PM
FibroGen (Filer)
Form DEF 14A
04/24/2024
4:08 PM
FibroGen (Filer)
Form DEFA14A
04/24/2024
3:15 PM
Adib Deyaa (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
4:58 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
6:06 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:17 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:18 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:19 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:33 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:28 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:29 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:37 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SC 13G
02/05/2024
7:08 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade
12/26/2023
6:28 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:19 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:20 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:21 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FGEN) was last updated on 12/5/2024 by MarketBeat.com Staff
From Our Partners